Returns
NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W
+0.35%
1M
+3.83%
3M
+12%
6M
+23.7%
YTD
+17.7%
1Y
+16.33%
2Y CAGR
+10.97%
3Y CAGR
+22.22%
5Y CAGR
+16.5%
10Y CAGR
—
SIP · XIRR on monthly instalments
6M SIP
+67.12%
1Y SIP
+33%
2Y SIP
+17.01%
3Y SIP
+18.65%
5Y SIP
+20.75%
10Y SIP
—
Full history SIP
+22.75%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.
Top holdings
as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
Sun Pharmaceutical Industries LtdPharmaceuticals & Biotechnology
8.42%
IPCA Laboratories LtdPharmaceuticals & Biotechnology
8.17%
Cipla LtdPharmaceuticals & Biotechnology
8.13%
Sai Life Sciences LtdPharmaceuticals & Biotechnology
7.1%
Gland Pharma LtdPharmaceuticals & Biotechnology
6.35%
Apollo Hospitals Enterprise LtdHealthcare Services
5.81%
Globus Medical IncHealthcare Equipment & Supplies
5.57%
Alkem Laboratories LtdPharmaceuticals & Biotechnology
4.66%
Cohance Lifesciences LtdPharmaceuticals & Biotechnology
3.75%
Vijaya Diagnostic Centre LtdHealthcare Services
3.47%
Top 10 61.43%Securities 30Securities total 93.54%Cash & equivalents 6.46%
The ten largest securities by weight, out of 30 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.
Risk
Volatility · annualised · 3Y
13.89%
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed.
Beta and alpha are not shown. No benchmark series in the source.
Cost
Expense ratio0.71%
Category average1.73%
Exit load0.5%
52W high / low₹51.237 / ₹39.918
Expense ratio 0.71% vs a category average of 1.73% — 1.02 percentage points lower. Among Sectoral/ Thematic schemes disclosing an expense ratio it is 5th of 166, cheapest first.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.
Scheme facts
SEBI sub-category
Sectoral/ Thematic
Plan / option
Direct Growth
Benchmark
BSE Health Care - TRI
Fund manager
Chirag Dagli
Launched
12 Nov 2018
NAV history here
7.7y
ISIN
INF740KA1LG1
AMFI scheme code
145454
SEBI riskometer
Very High
Exit load
0.5%
Lock-in
None
Minimum lumpsum
₹100
Exit load, as disclosed: 0.50% on or before 1M · Nil after 1M
Not shown on this page, and why
Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIP — Not present in the source.
Beta and alpha — No benchmark series in the source.